Tislelizumab Combined With SBRT for the Treatment of Head and Neck Squamous Cell Carcinoma

Clinical trial NCT06673693 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06673693
Sponsor: Sun Yat-sen University
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Head and Neck Squamous Cell Carcinoma (HNSCC)HNSCC

Start date: 2025-06-25
Primary completion: 2027-12-31
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.